Acrivon Therapeutics presents data on ACR-2316's tumor cell death mechanisms and early clinical trial results at AACR 2025. Acrivon Therapeutics has announced that it will present findings on ACR-2316 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results